| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12274-017-1500-Z |
| P2093 | author name string | Yong Zhu | |
| Qun Wang | |||
| Zhen Gu | |||
| Yun Jing | |||
| Shanshan Yao | |||
| Jicheng Yu | |||
| Jin Di | |||
| Dingjie Suo | |||
| Yanqi Ye | |||
| Matthew Pless | |||
| P2860 | cites work | Stretch-Triggered Drug Delivery from Wearable Elastomer Films Containing Therapeutic Depots. | Q44858972 |
| A new model for understanding the role of environmental factors in the origins of chronic illness: a case study of type 1 diabetes mellitus | Q45124118 | ||
| Glucose-responsive microgels integrated with enzyme nanocapsules for closed-loop insulin delivery. | Q50852281 | ||
| Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility. | Q51061971 | ||
| The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 | ||
| IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030 | Q29620059 | ||
| Ultrasound-triggered regulation of blood glucose levels using injectable nano-network. | Q30410088 | ||
| Driving delivery vehicles with ultrasound | Q30483826 | ||
| Enzymatically controlled drug delivery | Q33565428 | ||
| Ultrasound-mediated transdermal protein delivery | Q34302449 | ||
| Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery | Q34481917 | ||
| Therapeutic ultrasound: its application in drug delivery | Q34540070 | ||
| Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines | Q34557730 | ||
| Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study | Q34720231 | ||
| A microcomposite hydrogel for repeated on-demand ultrasound-triggered drug delivery | Q34773761 | ||
| Microfabricated drug delivery systems: from particles to pores | Q35082114 | ||
| Glucose-responsive insulin activity by covalent modification with aliphatic phenylboronic acid conjugates | Q35134731 | ||
| Managing diabetes with nanomedicine: challenges and opportunities | Q36574654 | ||
| The economic costs of diabetes: is it time for a new treatment paradigm? | Q36720338 | ||
| Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. | Q36890859 | ||
| The future of inhaled insulin and incretinmimetics in the management of diabetes | Q37236569 | ||
| Microbubbles as ultrasound triggered drug carriers | Q37315704 | ||
| Oral insulin: the rationale for this approach and current developments | Q37689830 | ||
| Remotely triggerable drug delivery systems | Q37785501 | ||
| Mechanical Force-Triggered Drug Delivery. | Q38966803 | ||
| Injectable nano-network for glucose-mediated insulin delivery | Q42744272 | ||
| P433 | issue | 4 | |
| P921 | main subject | glucose | Q37525 |
| microgels | Q110818712 | ||
| P304 | page(s) | 1393-1402 | |
| P577 | publication date | 2017-03-06 | |
| P1433 | published in | Nano Research | Q2181295 |
| P1476 | title | Ultrasound-triggered noninvasive regulation of blood glucose levels using microgels integrated with insulin nanocapsules | |
| P478 | volume | 10 |
Search more.